Endocrine Abnormalities and Growth Pattern in Single Large‐Scale Mitochondrial DNA Deletion Syndromes
Acta Paediatrica · 2025
DOI: 10.1111/apa.70040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Paediatrica, 2025. Verfasst von Ayman Daka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Ward, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel HaShomer, Israel. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Endocrine System Diseases, Mitochondrial Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aim
To assess the prevalence of endocrine disorders and investigate growth patterns in single large‐scale mitochondrial DNA deletion syndromes (SLSMDs).
Methods
A retrospective study of all children with SLSMD who attended Sheba Medical Center, Israel, from February 2017 to September 2024.
Results
The cohort included 18 individuals (9 males). The mean age at diagnosis was 4 ± 3.8 years and the mean age at analysis was 12 ± 5.2 years. All patients exhibited at least one endocrine disorder within 5 years post‐diagnosis. The most common were short stature (94%), hypoparathyroidism (83%), diabetes (33%), and delayed puberty (30%). A median of seven height measurements per individual produced 159 data points, which enabled generating unique growth charts. The mean puberty height‐SDS was significantly lower than that of the general population (−3.71 ± 1.17, p < 0.001). The mean Childhood and puberty height‐SDS were significantly reduced compared to the preschool period (−2.13 ± 1.13 vs. −3.35 ± 1.04, p = 0.01; −2.06 ± 1.03 vs. −3.71 ± 1.17, p = 0.007). The mean delta in height‐SDS from their parents and the mean insulin‐like growth factor 1‐SDS were lower than in the general population (2.36 ± 1.28, p = 0.0001 and − 1.53 ± 0.98, p < 0.0001, respectively).
Conclusion
All patients with SLSMD presented with endocrine disorders. Growth during childhood and adolescence was slower. Patients with SLSMD are predisposed to endocrine complications and should undergo timely and routine evaluations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Ward, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel HaShomer, Israel.
- Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.
- Pediatric Nephrology Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel HaShomer, Israel.
- Pediatric Neurology Unit, Edmond and Lily Safra Children's Hospital Sheba Medical Center, Tel HaShomer, Israel.
- Pediatric Cardiology Unit, Edmond and Lily Safra Children's Hospital Sheba Medical Center, Tel HaShomer, Israel.
- Pediatric Endocrinology and Diabetes Unit, Edmond and Lily Safra Children's Hospital Sheba Medical Center, Tel HaShomer, Israel.
ORCID-Profile: Ayman Daka, Yael Levy-Shraga, Noah Gruber
Zitieren
APA
Daka, A., Lahav, E., Yosef, O. B., Bolkier, Y., Levy-Shraga, Y., Anikster, Y., Jacoby, E., & Gruber, N. (2025). Endocrine Abnormalities and Growth Pattern in Single Large‐Scale Mitochondrial DNA Deletion Syndromes. Acta Paediatrica. https://doi.org/10.1111/apa.70040
Vancouver
Daka A, Lahav E, Yosef OB, Bolkier Y, Levy-Shraga Y, Anikster Y, et al. Endocrine Abnormalities and Growth Pattern in Single Large‐Scale Mitochondrial DNA Deletion Syndromes. Acta Paediatrica. 2025. doi:10.1111/apa.70040
BibTeX
@article{Daka2025,
author = {Daka, Ayman and Lahav, Einat and Yosef, Omer Bar and Bolkier, Yoav and Levy-Shraga, Yael and Anikster, Yair and Jacoby, Elad and Gruber, Noah},
title = {Endocrine Abnormalities and Growth Pattern in Single Large‐Scale Mitochondrial DNA Deletion Syndromes},
journal = {Acta Paediatrica},
year = {2025},
doi = {10.1111/apa.70040}
}
EUVIMED